ATRX and neoplasm: Interestingly, we found the tumour mutation burden was significantly elevated in TERT/ATRX-altered PCPG (one-sided Student’s t-test p < 0.001) consistent with a previous study11, but metastases from the TERT/ATRX wild-type cases had a low mutation burden (Fig. 6C).